The Management of Preeclampsia: A Comprehensive Review of Current Practices and Future Directions

Citations Over TimeTop 1% of 2024 papers

Abstract

Preeclampsia (PE) is a disease in pregnancy that is characterized by new-onset hypertension end-organ dysfunction, often occurring after 20 weeks of gestation. Risk factors include a prior history of PE, diabetes, kidney disease, obesity, and high maternal age at pregnancy. Current treatment and management guidelines focus on the management of high blood pressure and any potential complications. The only known curative treatment is termination of pregnancy (either induction of delivery or cesarean section). However, the current guidelines and recommendations lack adequate prediction markers and are unable to prevent maternal and fetal mortality. There also exists a need for multidisciplinary collaborative action in view of the quality of life and psycho-educational counseling.

Related Papers

• → Attitudes to the fetus among primigravidae(1982)56 cited
• → Ultrasonic evaluation of fetal body movements over twenty-four hours in the human fetus at twenty-four to twenty-eight weeks' gestation(1988)42 cited
• → Hormone Ontogeny in the Ovine Fetus. II. Ovine Chorionic Somatomammotropin in Mid and Late Gestation in the Fetal and Maternal Circulations*(1979)58 cited
• → Hormone Ontogeny in the Ovine Fetus. V. Circulating Prolactin in Mid- and Late Gestation and in the Newborn*(1979)33 cited
• Strontium-85 in the fetuses of pregnant rats and mice.(1985)